A detailed history of River Park Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, River Park Advisors, LLC holds 13,056 shares of EW stock, worth $854,906. This represents 1.01% of its overall portfolio holdings.

Number of Shares
13,056
Previous 13,056 -0.0%
Holding current value
$854,906
Previous $1.25 Million 3.37%
% of portfolio
1.01%
Previous 1.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $192,593 - $253,711
-2,655 Reduced 16.9%
13,056 $1.25 Million
Q4 2023

Jan 11, 2024

BUY
$61.71 - $77.76 $167,604 - $211,196
2,716 Added 20.9%
15,711 $1.2 Million
Q3 2023

Nov 08, 2023

BUY
$69.28 - $93.38 $10,392 - $14,007
150 Added 1.17%
12,995 $900,000
Q2 2023

Jul 27, 2023

SELL
$81.41 - $94.33 $41,112 - $47,636
-505 Reduced 3.78%
12,845 $1.21 Million
Q1 2023

May 03, 2023

SELL
$74.26 - $84.51 $24,134 - $27,465
-325 Reduced 2.38%
13,350 $1.1 Million
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $103,474 - $132,471
-1,515 Reduced 9.97%
13,675 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $41,185 - $53,645
-500 Reduced 3.19%
15,190 $1.26 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $1.38 Million - $2.04 Million
-15,940 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $122,351 - $154,008
-1,200 Reduced 7.0%
15,940 $1.88 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $958,925 - $1.18 Million
-9,015 Reduced 34.47%
17,140 $2.22 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $176,064 - $219,996
-2,100 Reduced 7.43%
26,155 $2.71 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $561,381 - $646,930
-7,135 Reduced 20.16%
28,255 $2.36 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $411,859 - $524,116
-5,745 Reduced 13.97%
35,390 $3.23 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $280,518 - $365,062
-4,175 Reduced 9.21%
41,135 $3.28 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.27 Million - $1.7 Million
22,040 Added 94.71%
45,310 $3.13 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $871,316 - $1.35 Million
-16,625 Reduced 41.67%
23,270 $4.39 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $25,883 - $29,634
-361 Reduced 0.9%
39,895 $9.31 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $307,134 - $376,395
-4,990 Reduced 11.03%
40,256 $8.85 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $395,754 - $457,311
-7,100 Reduced 13.56%
45,246 $8.36 Million
Q1 2019

May 09, 2019

SELL
$47.89 - $64.05 $507,634 - $678,930
-10,600 Reduced 16.84%
52,346 $10 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $2.03 Million - $2.49 Million
-43,750 Reduced 41.0%
62,946 $9.64 Million
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $1.59 Million - $2.02 Million
-34,804 Reduced 24.6%
106,696 $18.6 Million
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $912,675 - $1.1 Million
-21,500 Reduced 13.19%
141,500 $20.6 Million
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $3.96 Million - $5.05 Million
-106,500 Reduced 39.52%
163,000 $22.7 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $591,325 - $689,325
-17,500 Reduced 6.1%
269,500 $30.4 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $10.4 Million - $11.1 Million
287,000
287,000 $31.4 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.